Found 4 matching trials
Study of MEDI-524 (Motavizumab) for the Prophylaxis of Serious Respiratory Syncytial Virus (RSV) Disease in High-Risk Children
PHASE3The primary objective of this study was to compare the safety and efficacy ...
Location
University Of Alabama At Birmingham
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of Motavizumab (MEDI-524) After Dosing for a Second Season in Children
PHASE1The primary objective of this study was to determine the effect on immune r...
Location
Pontificia Universidade Catolica Do Rio Grande
Study of Motavizumab (MEDI-524) and Palivizumab Administered Sequentially in the Same Respiratory Syncytial Virus (RSV) Season
PHASE2This is a Phase 2, randomized, double-blind study in which motavizumab (MED...
Location
Department of Paediatrics and Child Health, The Canberra Hospital
A Study to Evaluate MEDI-524 In Children With Hemodynamically Significant Congenital Heart Disease
PHASE2The primary goal was to describe the safety of the investigational product ...
Location
Arkansas Pediatric Clinic